MetaCap

Cue Biopharma Insider Trades

NASDAQ: CUEHealth CareBiotechnology: Pharmaceutical PreparationsUSD

4.15-0.35 (-7.78%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
5 · $99.75K
Sales
15 · $2.43M
Shares bought / sold
323.86K / 86.79K
Net activity
Net selling $2.3 million

Cue Biopharma insider activity

Over the last 12 months, Cue Biopharma insiders reported 35 transactions on SEC Form 4: 5 open-market purchases and 15 sales. Insiders bought $99,747 and sold $2.4 million worth of stock, for net insider selling of $2.3 million. The largest seller was Lin Shao-Lee, with $1.9 million in reported sales.

The most recent filing shows Meluzio Michael Vincent (VP, Prin. Accounting Officer) selling 1,144 shares at $28.05 on Oct 12, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CUE's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

CUE insider transactions

Cue Biopharma insider transactions
DateInsiderTypeSharesValueFiling
Oct 12, 2026Lin Shao-LeeChief Executive OfficerSale1,087$30.49KForm 4
Oct 12, 2026Lin Shao-LeeChief Executive OfficerSale10,000$275.00KForm 4
Oct 12, 2026Ray SumitaChief Legal Compliance OfficerSale1,844$51.72KForm 4
Oct 12, 2026Meluzio Michael VincentVP, Prin. Accounting OfficerSale1,144$32.09KForm 4
Aug 13, 2026Lin Shao-LeeChief Executive OfficerSale10,460$308.36KForm 4
Aug 13, 2026Lin Shao-LeeChief Executive OfficerSale2,375$66.76KForm 4
Aug 13, 2026Lin Shao-LeeChief Executive OfficerSale5,423$147.45KForm 4
Aug 13, 2026Meluzio Michael VincentVP, Prin. Accounting OfficerSale3$93.39Form 4
Aug 13, 2026Meluzio Michael VincentVP, Prin. Accounting OfficerSale4,106$124.62KForm 4
Aug 13, 2026Meluzio Michael VincentVP, Prin. Accounting OfficerSale1,519$44.61KForm 4
Aug 13, 2026Meluzio Michael VincentVP, Prin. Accounting OfficerOption exercise13,647—Form 4
Aug 13, 2026Ray SumitaChief Legal Compliance OfficerSale4$124.52Form 4
Aug 13, 2026Ray SumitaChief Legal Compliance OfficerSale6,442$195.51KForm 4
Aug 13, 2026Ray SumitaChief Legal Compliance OfficerSale2,383$69.99KForm 4
Aug 13, 2026Ray SumitaChief Legal Compliance OfficerOption exercise18,196—Form 4
Aug 12, 2026Lin Shao-LeeChief Executive OfficerSale5,775$160.26KForm 4
Aug 12, 2026Lin Shao-LeeChief Executive OfficerSale34,225$923.73KForm 4
Aug 12, 2026Lin Shao-LeeChief Executive OfficerOption exercise109,179—Form 4
Jul 30, 2026Ahlers James MChief Financial OfficerAward25,500—Form 4
Jul 13, 2026Borie Dominique ChristianChief Medical OfficerAward31,500—Form 4
Jul 9, 2026Lin Shao-LeeChief Executive OfficerAward327,537—Form 4
Jul 9, 2026Meluzio Michael VincentVP, Prin. Accounting OfficerAward40,942—Form 4
Jul 9, 2026Sarraf PashaDirectorAward21,800—Form 4
Jul 9, 2026Garzone PamelaDirectorAward21,800—Form 4
Jul 9, 2026Ray SumitaChief Legal Compliance OfficerAward54,589—Form 4
Jul 9, 2026Meehan Viola MongDirectorAward21,800—Form 4
Jul 9, 2026Camardo Daniel A.DirectorAward21,800—Form 4
Jul 9, 2026Garzone PamelaDirectorAward18,900—Form 4
Jul 9, 2026Sarraf PashaDirectorAward18,400—Form 4
May 3, 2026Lin Shao-LeeCHIEF EXECUTIVE OFFICERAward327,537—Form 4
Dec 30, 2025Sarraf PashaDirectorBuy77,417$23.35KForm 4
Dec 30, 2025Sarraf PashaDirectorBuy78,116$24.33KForm 4
Dec 30, 2025Sarraf PashaDirectorBuy86,947$27.60KForm 4
Dec 30, 2025Sarraf PashaDirectorBuy77,148$23.17KForm 4
Dec 30, 2025Sarraf PashaDirectorBuy4,229$1.31KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related